10 May 2022 | News
The company is ready to scale new heights and make its products more accessible to its consumers
Medtech startup Agatsa, based in Noida, has raised Rs 125 million to grow business operations and expand the product line. The company aims to revolutionise the cardiac care industry in India. With this new funding, the company is ready to scale new heights and make its products more accessible to its consumers.
Key investors include seasoned medical experts Dr Ramakant Panda, MCh, Chief Consultant for Cardiovascular Thoracic Surgery and the Vice Chairman and MD of the Asian Heart Institute, BKC, Mumbai; Dr Tejas Patel, a renowned cardiologist and Chairman of Apex Heart Institute, Ahmedabad; Dr Ashish Parikh, Interventional Clinical Cardiologist and Chairman of Heart and Vascular Clinic in Delaware, US, Ahmedabad based Desai Family and Hemal Patel, a successful serial entrepreneur. Fairprep Ally (India) represented by CEO Nirav Thakkar, based in Ahmedabad, Gujarat has facilitated the funding transaction as the investment banker.
Agatsa is also gearing up for expansion in the US and European markets with their CE and FDA certification under process. Agatsa has innovated the world’s first pocket 12-Lead ECG device which is 99% accurate and is being used by both doctors and heart patients in India for quick diagnosis/detection of cardiac problems. The device is very simple to use, affordable and pocket-sized anyone can easily use it on the go.